COPD assessment tests scores are associated with exacerbated chronic obstructive pulmonary disease in Japanese patients

Respiratory Investigation

Volumn 52, Issue 5, 2014, Pages 288-295

  Suetomo, Masashi ^a,b   Kawayama, Tomotaka ^a   Kinoshita, Takashi ^a   Takenaka, Shinichi ^a   Matsuoka, Masanobu ^a   Matsunaga, Kazuko ^a   Hoshino, Tomoaki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chikugo City Hospital   (Japan)

Author keywords

COPD; Quality of life; Questionnaire; Respiratory function tests

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT;

AGE; AGED; AIRWAY OBSTRUCTION; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE ASSESSMENT TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITALIZATION; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE COURSE; LUNG FUNCTION TEST; LUNG VENTILATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK MANAGEMENT; STATISTICAL MODEL;

AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS; RISK MANAGEMENT; ROC CURVE;

EID: 84906790433     PISSN: 22125345     EISSN: 22125353     Source Type: Journal    
DOI: 10.1016/j.resinv.2014.04.004     Document Type: Article

References (33)

1. Marchetti N., Criner G.J., Albert R.K. Preventing acute exacerbations and hospital admissions in COPD. Chest 2013, 143:1444-1454.
2. Esteban C., Quintana J.M., Moraza J., et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009, 103:1201-1208.
3. Miravitlles M., Ferrer M., Pont A., et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004, 59:387-395.
4. Seemungal T.A., Donaldson G.C., Paul E.A., et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422.
5. Fan V.S., Curtis J.R., Tu S.P., et al. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002, 122:429-436.
6. Domingo-Salvany A., Lamarca R., Ferrer M., et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:680-685.
7. Crawford B., Monz B., Hohlfeld J., et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med 2008, 102:1545-1555.
8. Leidy N.K., Schmier J.K., Jones M.K., et al. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale. Respir Med 2003, 97(Suppl A):S59-S70.
9. Miravitlles M. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med 2011, 105:1118-1128.
10. Burgel P.R., Nesme-Meyer P., Chanez P., et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009, 135:975-982.
11. Ekberg-Aronsson M., Pehrsson K., Nilsson J.A., et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005, 6:98.
12. Steer J., Norman E.M., Afolabi O.A., et al. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 2012, 67:117-121.
13. Schembri S., Anderson W., Morant S., et al. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med 2009, 103:1461-1467.
14. Nishimura K., Izumi T., Tsukino M., et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002, 121:1434-1440.
15. Doll H., Grey-Amante P., Duprat-Lomon I., et al. Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. Respir Med 2002, 96:39-51.
16. Jones P.W., Harding G., Berry P., et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009, 34:648-654.
17. Jones P.W., Brusselle G., Dal Negro R.W., et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011, 38:29-35.
18. Tsuda T., Suematsu R., Kamohara K., et al. Development of the Japanese version of the COPD Assessment Test. Respir Investig 2012, 50:34-39.
19. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO workshop report; 2011.
20. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
21. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000, 117:398S-401S.
22. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789.
23. Lange P., Marott J.L., Vestbo J., et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012, 186:975-981.
24. Tanabe N., Muro S., Hirai T., et al. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011, 183:1653-1659.
25. Fukuchi Y., Fernandez L., Kuo H.P., et al. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Respirology 2011, 16:825-835.
26. Finucane M.M., Stevens G.A., Cowan M.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
27. Tatsumi K., Kasahara Y., Kurosu K., et al. Clinical phenotypes of COPD: results of a Japanese epidemiological survey. Respirology 2004, 9:331-336.
28. Raghavan N., Lam Y.M., Webb K.A., et al. Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD 2012, 9:175-183.
29. Chetta A., Olivieri D. The COPD Assessment Test in the evaluation of chronic obstructive pulmonary disease exacerbations. Expert Rev Respir Med 2012, 6:373-375.
30. Agusti A., Soler J.J., Molina J., et al. Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?. COPD 2012, 9:492-498.
31. Mackay A.J., Donaldson G.C., Patel A.R., et al. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012, 185:1218-1224.
32. Dodd J.W., Marns P.L., Clark A.L., et al. The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD 2012, 9:390-394.
33. Feliz-Rodriguez D., Zudaire S., Carpio C., et al. Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value. Can Respir J 2013, 20:e92-e97.